Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
Recruiting · NCT07014007 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Erythema, Hypersensitivity, Immediate, Neurologic Manifestations, Paresthesia, Pathological Conditions, Signs and Symptoms, Pruritus, Sensation Disorders, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, Somatosensory Disorders, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, nervous system disorder, skin disorder | Recruiting | Not applicable | 2026-05-05 | NCT07014007 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pierre Fabre Dermo Cosmetique | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Insight Research Ltd | Quatre Bornes | Mauritius | 1 |